Healthy Extracts (HYEX) Non-Current Assets (2015 - 2026)
Healthy Extracts (HYEX) posted quarterly Non-Current Assets of $26.5 million for Q4 2025, up 3587.43% year-over-year from $718586.0 in Q4 2024, and up 8.32% quarter-over-quarter from $24.5 million in Q3 2025.
Healthy Extracts (HYEX) Non-Current Assets (2015 - 2026) Analysis & Trends
Healthy Extracts' Non-Current Assets history runs 11 years deep, the most recent figure standing at $26.5 million for Q4 2025.
- In Q4 2025, Non-Current Assets rose 3587.43% year-over-year to $26.5 million; the TTM figure through Dec 2025 stood at $52.8 million (up 1756.6% YoY), while the FY2025 annual figure was $26.5 million, up 3587.43% from the prior year.
- Non-Current Assets for Q4 2025 stood at $26.5 million, up from $24.5 million in the prior quarter.
- The five-year high for Non-Current Assets was $26.5 million in Q4 2025, with the low at -$2.2 million in Q1 2022.
- The 5-year median for Non-Current Assets is $678996.5 (2021), against an average of $2.4 million.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 545.28% in 2024, then surged 8574.77% in 2025.
- Healthy Extracts' Non-Current Assets stood at $716175.0 in 2021, then gained by 2.98% to $737531.0 in 2022, then declined by 0.3% to $735336.0 in 2023, then retreated by 2.28% to $718586.0 in 2024, then surged by 3587.43% to $26.5 million in 2025.
- Business Quant data shows HYEX's Non-Current Assets at $26.5 million in Q4 2025, $24.5 million in Q3 2025, and $934894.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | 30.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.93 Mn |
| Dec 31, 2025 | 26.50 Mn |
| Sep 30, 2025 | 24.46 Mn |
| Jun 30, 2025 | 934,894.00 |
| Mar 31, 2025 | 930,805.00 |
| Dec 31, 2024 | 718,586.00 |
| Sep 30, 2024 | -288,653.00 |
| Jun 30, 2024 | -1.75 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | 735,336.00 |
| Sep 30, 2023 | -377,096.00 |
| Jun 30, 2023 | -271,008.00 |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | 737,531.00 |
| Sep 30, 2022 | -174,639.00 |
| Jun 30, 2022 | -152,806.00 |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | 716,175.00 |
| Sep 30, 2021 | 706,334.00 |
| Jun 30, 2021 | 696,109.00 |